Methods and compositions for improving the appearance of skin
First Claim
Patent Images
1. A method for stimulating collagen synthesis in skin cells in need of such treatment by topically applying a composition comprising at least one extract from Laminaria genus, at least one extract from the Narcissus genus, and at least one peptide of the formula (I):
- R1-(AA)n-X1-X2-X3-X4-X5-X6-(AA)p-R2, in whichX1 is glycine or threonine or histidine;
X2 is alanine or glutamine or glycine;
X3 is glycine or asparagine or serine;
X4 is valine or isoleucine or leucine;
X5 is serine or aspartic acid or phenylalanine;
X6 is alanine or glutamic acid or lysine;
whereinwhen X1 is glycine, then X2 is alanine and X3 is glycine;
when X1 is threonine, then X3 is asparagine;
when X1 is histidine, then X2 is glycine;
AA represents any amino acid and n and p are integers between 0 and 2;
R1 represents the primary amino function of the N-terminal amino acid, free or substituted by an acyl type group having either an alkyl chain from C1-30, saturated or unsaturated, that may be an acetyl group, or an aromatic group that may be chosen from among a benzoyl, tosyl or benzyloxycarbonyl type group; and
R2 represents the hydroxyl group of the carboxyl function of the C-terminal amino acid, free or substituted by a group that may be chosen from among an alkyl chain from C1-30, or an NH2, NHY or NYY group with Y representing an alkyl chain from C1-4 wherein the extract from the Laminaria genus is present at 0.001 to 1%, the extract from Narcissus genus is present at 0.001 to 1.5% and the peptide is present from 0.0001 to 1%, with all percentages by weight of the total composition.
0 Assignments
0 Petitions
Accused Products
Abstract
A method for stimulating collagen synthesis in aging skin cells in need of treatment by stimulating SIRT1, SIRT3, and SIRT6 and a method for preparing a topical composition for stimulating SIRT1, SIRT3, and SIRT6 in skin cells.
16 Citations
14 Claims
-
1. A method for stimulating collagen synthesis in skin cells in need of such treatment by topically applying a composition comprising at least one extract from Laminaria genus, at least one extract from the Narcissus genus, and at least one peptide of the formula (I):
-
R1-(AA)n-X1-X2-X3-X4-X5-X6-(AA)p-R2, in which X1 is glycine or threonine or histidine; X2 is alanine or glutamine or glycine; X3 is glycine or asparagine or serine; X4 is valine or isoleucine or leucine; X5 is serine or aspartic acid or phenylalanine; X6 is alanine or glutamic acid or lysine;
whereinwhen X1 is glycine, then X2 is alanine and X3 is glycine; when X1 is threonine, then X3 is asparagine; when X1 is histidine, then X2 is glycine; AA represents any amino acid and n and p are integers between 0 and 2; R1 represents the primary amino function of the N-terminal amino acid, free or substituted by an acyl type group having either an alkyl chain from C1-30, saturated or unsaturated, that may be an acetyl group, or an aromatic group that may be chosen from among a benzoyl, tosyl or benzyloxycarbonyl type group; and R2 represents the hydroxyl group of the carboxyl function of the C-terminal amino acid, free or substituted by a group that may be chosen from among an alkyl chain from C1-30, or an NH2, NHY or NYY group with Y representing an alkyl chain from C1-4 wherein the extract from the Laminaria genus is present at 0.001 to 1%, the extract from Narcissus genus is present at 0.001 to 1.5% and the peptide is present from 0.0001 to 1%, with all percentages by weight of the total composition. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
Specification